Journal of Human Nutrition & Dietetics 32 (4): 518524
What the research on hCG dosing frequency reveals is that how you protect it may matter just as much as whether you do
Sikiric's lab in Croatia) No independent replication No competing research Raises red flags about bias Human data: ONE small retrospective study (not a randomized trial) No large-scale clinical trials No safety studies Unknown dosing Unknown side effects Recent systematic review (2024): Published in orthopaedic literature, concluded: "BPC-157 has potential based on preclinical data, but there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without publication." Reported Side Effects (From Online Users): Anonymous reports include: Injection site pain and swelling Joint pain Anxiety and panic attacks Heart palpitations Insomnia or drowsiness Fatigue and weakness Loss of appetite Depression and anhedonia (inability to feel pleasure) Note: These are anecdotal, not from clinical trials
Generally feel "younger or like yourself again: Ask your clinician about hormone therapy or non-hormonal treatments, and prioritize other healthy lifestyle strategies like doing regular exercise, following a nutritious diet, and getting plenty of sleep
(Midi does not prescribe this or other unapproved peptides.) What the science says: Ipamorelin has more clinical data than many other peptides featured in this guide, but the evidence is still lacking
Oral BPC-157 bioavailability is estimated at 515% of subcutaneous administration due to first-pass hepatic metabolism and gastric peptide degradation
